138 related articles for article (PubMed ID: 9545222)
21. Transcriptional control of the agr-dependent virulence gene regulator, RNAIII, in Staphylococcus aureus.
Morfeldt E; Tegmark K; Arvidson S
Mol Microbiol; 1996 Sep; 21(6):1227-37. PubMed ID: 8898391
[TBL] [Abstract][Full Text] [Related]
22. Expression of an antisense hla fragment in Staphylococcus aureus reduces alpha-toxin production in vitro and attenuates lethal activity in a murine model.
Kernodle DS; Voladri RK; Menzies BE; Hager CC; Edwards KM
Infect Immun; 1997 Jan; 65(1):179-84. PubMed ID: 8975909
[TBL] [Abstract][Full Text] [Related]
23. RNAIII suppresses the expression of LtaS via acting as an antisense RNA in Staphylococcus aureus.
Yan J; Liu Y; Gao Y; Dong J; Mu C; Li D; Yang G
J Basic Microbiol; 2015 Feb; 55(2):255-61. PubMed ID: 25283303
[TBL] [Abstract][Full Text] [Related]
24. Staphylococcus aureus RNAIII coordinately represses the synthesis of virulence factors and the transcription regulator Rot by an antisense mechanism.
Boisset S; Geissmann T; Huntzinger E; Fechter P; Bendridi N; Possedko M; Chevalier C; Helfer AC; Benito Y; Jacquier A; Gaspin C; Vandenesch F; Romby P
Genes Dev; 2007 Jun; 21(11):1353-66. PubMed ID: 17545468
[TBL] [Abstract][Full Text] [Related]
25. A novel peptide isolated from phage library to substitute a complex system for a vaccine against staphylococci infection.
Yang G; Gao Y; Dong J; Xue Y; Fan M; Shen B; Liu C; Shao N
Vaccine; 2006 Feb; 24(8):1117-23. PubMed ID: 16359760
[TBL] [Abstract][Full Text] [Related]
26. Growth phase-dependent regulation of the global virulence regulator Rot in clinical isolates of Staphylococcus aureus.
Jelsbak L; Hemmingsen L; Donat S; Ohlsen K; Boye K; Westh H; Ingmer H; Frees D
Int J Med Microbiol; 2010 Apr; 300(4):229-36. PubMed ID: 19665927
[TBL] [Abstract][Full Text] [Related]
27. Inhibition of rot translation by RNAIII, a key feature of agr function.
Geisinger E; Adhikari RP; Jin R; Ross HF; Novick RP
Mol Microbiol; 2006 Aug; 61(4):1038-48. PubMed ID: 16879652
[TBL] [Abstract][Full Text] [Related]
28. The 5' NAD Cap of RNAIII Modulates Toxin Production in Staphylococcus aureus Isolates.
Morales-Filloy HG; Zhang Y; Nübel G; George SE; Korn N; Wolz C; Jäschke A
J Bacteriol; 2020 Feb; 202(6):. PubMed ID: 31871032
[TBL] [Abstract][Full Text] [Related]
29. A small regulatory RNA alters Staphylococcus aureus virulence by titrating RNAIII activity.
Le Huyen KB; Gonzalez CD; Pascreau G; Bordeau V; Cattoir V; Liu W; Bouloc P; Felden B; Chabelskaya S
Nucleic Acids Res; 2021 Oct; 49(18):10644-10656. PubMed ID: 34554192
[TBL] [Abstract][Full Text] [Related]
30. Prophylactic efficacy of topical temporin A and RNAIII-inhibiting peptide in a subcutaneous rat Pouch model of graft infection attributable to staphylococci with intermediate resistance to glycopeptides.
Cirioni O; Giacometti A; Ghiselli R; Dell'Acqua G; Gov Y; Kamysz W; Lukasiak J; Mocchegiani F; Orlando F; D'Amato G; Balaban N; Saba V; Scalise G
Circulation; 2003 Aug; 108(6):767-71. PubMed ID: 12885754
[TBL] [Abstract][Full Text] [Related]
31. Regulation of virulence determinants in Staphylococcus aureus.
Arvidson S; Tegmark K
Int J Med Microbiol; 2001 May; 291(2):159-70. PubMed ID: 11437338
[TBL] [Abstract][Full Text] [Related]
32. Panton-Valentine leucocidin and severe Staphylococcus aureus infections of the skin: sole culprit or does it have accomplices?
Hay R; Noor NM
Curr Opin Infect Dis; 2011 Apr; 24(2):97-9. PubMed ID: 21169830
[No Abstract] [Full Text] [Related]
33. Staphylococcus aureus RNAIII and Its Regulon Link Quorum Sensing, Stress Responses, Metabolic Adaptation, and Regulation of Virulence Gene Expression.
Bronesky D; Wu Z; Marzi S; Walter P; Geissmann T; Moreau K; Vandenesch F; Caldelari I; Romby P
Annu Rev Microbiol; 2016 Sep; 70():299-316. PubMed ID: 27482744
[TBL] [Abstract][Full Text] [Related]
34. Improved protective efficacy of a chimeric Staphylococcus aureus vaccine candidate iron-regulated surface determinant B ( N 126- P 361) -target of RNAIII activating protein in mice.
Yu L; Wang N; Ma J; Tong C; Song B; Chi J; Ma G; Zhu Z; Cui Y
Microbiol Immunol; 2013 Dec; 57(12):857-64. PubMed ID: 24117875
[TBL] [Abstract][Full Text] [Related]
35. TRAP plays a role in stress response in Staphylococcus aureus.
Kiran MD; Balaban N
Int J Artif Organs; 2009 Sep; 32(9):592-9. PubMed ID: 19856271
[TBL] [Abstract][Full Text] [Related]
36. Cloning and characterization of an accessory gene regulator (agr)-like locus from Staphylococcus epidermidis.
Van Wamel WJ; van Rossum G; Verhoef J; Vandenbroucke-Grauls CM; Fluit AC
FEMS Microbiol Lett; 1998 Jun; 163(1):1-9. PubMed ID: 9631538
[TBL] [Abstract][Full Text] [Related]
37. VraR Binding to the Promoter Region of
Dai Y; Chang W; Zhao C; Peng J; Xu L; Lu H; Zhou S; Ma X
Antimicrob Agents Chemother; 2017 May; 61(5):. PubMed ID: 28289032
[TBL] [Abstract][Full Text] [Related]
38. Global virulence regulation in Staphylococcus aureus: pinpointing the roles of ClpP and ClpX in the sar/agr regulatory network.
Frees D; Sørensen K; Ingmer H
Infect Immun; 2005 Dec; 73(12):8100-8. PubMed ID: 16299304
[TBL] [Abstract][Full Text] [Related]
39. An experimental vaccine that targets staphylococcal virulence.
Lee JC
Trends Microbiol; 1998 Dec; 6(12):461-3. PubMed ID: 10036720
[No Abstract] [Full Text] [Related]
40. Staphylococcus aureus CcpA affects virulence determinant production and antibiotic resistance.
Seidl K; Stucki M; Ruegg M; Goerke C; Wolz C; Harris L; Berger-Bächi B; Bischoff M
Antimicrob Agents Chemother; 2006 Apr; 50(4):1183-94. PubMed ID: 16569828
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
